TSVT Overview
Upcoming Projects (TSVT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TSVT)
-
A Second Look: Discussing the KarMMa Phase 2 Cohorts 2a and 2c Study Results of Abecma(idecabtagene vicleucel) in R/R multiple myeloma presented at the ASH 2022 conference
Tickers: TSVT, BMY
Executed On: Jan 09, 2023 at 06:15 PM EST -
Discussing the KarMMa Phase 2 Cohorts 2a and 2c Study Results of Abecma(idecabtagene vicleucel) in R/R multiple myeloma presented at the ASH 2022 conference
Tickers: TSVT, BMY
Executed On: Dec 19, 2022 at 03:00 PM EST -
A look at the potential of new CAR-T cell therapies in development for multiple myeloma
Tickers: ACLX, GRCL, OriCell Therapeutics, JNJ, LEGN, TSVT
Executed On: Jul 14, 2022 at 08:00 AM EDT -
Discussion on BCMA targeted therapies in multiple myeloma - second look
Tickers: LEGN, TSVT, BMY, JNJ
Executed On: Feb 23, 2022 at 07:00 PM EST -
A look at upcoming Cilta-cel PDUFA and other BCMA directed therapies
Tickers: LEGN, BMY, TSVT, JNJ
Executed On: Feb 17, 2022 at 03:00 PM EST
Upcoming & Overdue Catalysts (TSVT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TSVT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
